Clinical Trial Update: Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

View source ↗

Summary

An ongoing clinical trial is evaluating whether dexrazoxane hydrochloride affects biomarkers linked to cardiomyopathy and heart failure after cancer treatment. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Leukemia
• Lymphoblastic Lymphoma
• Lymphoma
• Malignant Neoplasm
• Osteosarcoma

Drugs mentioned

• DEXRAZOXANE (DEXRAZOXANE)

Snippet

Sponsor: Children's Oncology Group | Conditions: Hodgkin Lymphoma in Remission, Leukemia in Remission | Status: RECRUITING